CHELSEA CENTURIONI: Open Payments
NPI 1013463686 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,936 in 80 payments from 16 companies in 2025. Trend: 2023 $669 · 2024 $989 · 2025 $1,936
Food & beverage: $1,811Education: $100Consulting: $25
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $357 |
| GlaxoSmithKline, LLC. | 17 | $351 |
| HARMONY BIOSCIENCES LLC | 5 | $229 |
| Amgen Inc. | 9 | $196 |
| Regeneron Healthcare Solutions, Inc. | 5 | $160 |
| Verona Pharma, Inc. | 4 | $126 |
| Pulmonx Corporation | 5 | $125 |
| PFIZER INC. | 4 | $101 |
| Viatris Specialty LLC | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
Products named: NUCALA, TEZSPIRE, AIRSUPRA, DUPIXENT, WAKIX, Ohtuvayre, CHARTIS CATHETER, BREZTRI.
Industry payments across NY — which companies pay providers there.
